Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 117

1.

Influenza epidemiology and influenza vaccine effectiveness during the 2015-2016 season: results from the Global Influenza Hospital Surveillance Network.

Puig-Barberà J, Mira-Iglesias A, Burtseva E, Cowling BJ, Serhat U, Ruiz-Palacios GM, Launay O, Kyncl J, Koul P, Siqueira MM, Sominina A; Global Influenza Hospital Surveillance Network.

BMC Infect Dis. 2019 May 14;19(1):415. doi: 10.1186/s12879-019-4017-0.

2.

Efficacy and Safety of Nitazoxanide in Addition to Standard of Care for the Treatment of Severe Acute Respiratory Illness.

Gamiño-Arroyo AE, Guerrero ML, McCarthy S, Ramírez-Venegas A, Llamosas-Gallardo B, Galindo-Fraga A, Moreno-Espinosa S, Roldán-Aragón Y, Araujo-Meléndez J, Hunsberger S, Ibarra-González V, Martínez-López J, García-Andrade LA, Kapushoc H, Holley HP Jr, Smolskis MC, Ruiz-Palacios GM, Beigel JH; Mexico Emerging Infectious Diseases Clinical Research Network (LaRed).

Clin Infect Dis. 2019 Feb 7. doi: 10.1093/cid/ciz100. [Epub ahead of print]

PMID:
30753384
3.

Underweight, overweight, and obesity as independent risk factors for hospitalization in adults and children from influenza and other respiratory viruses.

Moser JS, Galindo-Fraga A, Ortiz-Hernández AA, Gu W, Hunsberger S, Galán-Herrera JF, Guerrero ML, Ruiz-Palacios GM, Beigel JH; La Red ILI 002 Study Group.

Influenza Other Respir Viruses. 2019 Jan;13(1):3-9. doi: 10.1111/irv.12618. Epub 2018 Dec 4.

4.

"Differential risk of hospitalization among single virus infections causing influenza-like illnesses".

Ortiz-Hernández AA, Nishimura KK, Noyola DE, Moreno-Espinosa S, Gamiño A, Galindo-Fraga A, Valdéz Vázquez R, Magaña Aquino M, Ramirez-Venegas A, Valdés Salgado R, Andrade-Platas D, Estevez-Jimenéz J, Ruiz-Palacios GM, Guerrero ML, Beigel J, Smolskis MC, Hunsberger S, Freimanis-Hence L, Llamosas-Gallardo B; Mexico Emerging Infectious Diseases Clinical Research Network (La Red).

Influenza Other Respir Viruses. 2019 Jan;13(1):36-43. doi: 10.1111/irv.12606. Epub 2018 Oct 16.

5.

Detection of VBNC Vibrio cholerae by RT-Real Time PCR based on differential gene expression analysis.

Casasola-Rodríguez B, Ruiz-Palacios GM, Pilar RC, Losano L, Ignacio MR, Orta de Velásquez MT.

FEMS Microbiol Lett. 2018 Aug 1;365(15). doi: 10.1093/femsle/fny156.

PMID:
29961811
6.

Performance of the inFLUenza Patient-Reported Outcome (FLU-PRO) diary in patients with influenza-like illness (ILI).

Powers JH 3rd, Bacci ED, Leidy NK, Poon JL, Stringer S, Memoli MJ, Han A, Fairchok MP, Coles C, Owens J, Chen WJ, Arnold JC, Danaher PJ, Lalani T, Burgess TH, Millar EV, Ridore M, Hernández A, Rodríguez-Zulueta P, Ortega-Gallegos H, Galindo-Fraga A, Ruiz-Palacios GM, Pett S, Fischer W, Gillor D, Moreno Macias L, DuVal A, Rothman R, Dugas A, Guerrero ML.

PLoS One. 2018 Mar 22;13(3):e0194180. doi: 10.1371/journal.pone.0194180. eCollection 2018.

7.

Reliability, Validity, and Responsiveness of InFLUenza Patient-Reported Outcome (FLU-PRO©) Scores in Influenza-Positive Patients.

Powers JH 3rd, Bacci ED, Guerrero ML, Leidy NK, Stringer S, Kim K, Memoli MJ, Han A, Fairchok MP, Chen WJ, Arnold JC, Danaher PJ, Lalani T, Ridoré M, Burgess TH, Millar EV, Hernández A, Rodríguez-Zulueta P, Smolskis MC, Ortega-Gallegos H, Pett S, Fischer W, Gillor D, Macias LM, DuVal A, Rothman R, Dugas A, Ruiz-Palacios GM.

Value Health. 2018 Feb;21(2):210-218. doi: 10.1016/j.jval.2017.04.014. Epub 2017 Jun 7.

8.

A place for Bordetella pertussis in PCR-based diagnosis of community-acquired pneumonia.

Luis BAL, Guerrero Almeida ML, Ruiz-Palacios GM.

Infect Dis (Lond). 2018 Mar;50(3):232-235. doi: 10.1080/23744235.2017.1384958. Epub 2017 Sep 28. No abstract available.

PMID:
28958186
9.

High HPgV replication is associated with improved surrogate markers of HIV progression.

Horemheb-Rubio G, Ramos-Cervantes P, Arroyo-Figueroa H, Ávila-Ríos S, García-Morales C, Reyes-Terán G, Escobedo G, Estrada G, García-Iglesias T, Muñoz-Saucedo N, Kershenobich D, Ostrosky-Wegman P, Ruiz-Palacios GM.

PLoS One. 2017 Sep 14;12(9):e0184494. doi: 10.1371/journal.pone.0184494. eCollection 2017.

10.

Naturally Acquired Immunity Against Rotavirus Infection and Gastroenteritis in Children: Paired Reanalyses of Birth Cohort Studies.

Lewnard JA, Lopman BA, Parashar UD, Bar-Zeev N, Samuel P, Guerrero ML, Ruiz-Palacios GM, Kang G, Pitzer VE.

J Infect Dis. 2017 Aug 1;216(3):317-326. doi: 10.1093/infdis/jix310.

11.

Branched-chain fatty acid composition of human milk and the impact of maternal diet: the Global Exploration of Human Milk (GEHM) Study.

Dingess KA, Valentine CJ, Ollberding NJ, Davidson BS, Woo JG, Summer S, Peng YM, Guerrero ML, Ruiz-Palacios GM, Ran-Ressler RR, McMahon RJ, Brenna JT, Morrow AL.

Am J Clin Nutr. 2017 Jan;105(1):177-184. doi: 10.3945/ajcn.116.132464. Epub 2016 Nov 30.

12.

Immunogenicity of AS03-adjuvanted and non-adjuvanted trivalent inactivated influenza vaccines in elderly adults: A Phase 3, randomized trial and post-hoc correlate of protection analysis.

Ruiz-Palacios GM, Leroux-Roels G, Beran J, Devaster JM, Esen M, Launay O, McElhaney JE, van Essen GA, Benoit A, Claeys C, Dewé W, Durand C, Duval X, Falsey AR, Feldman G, Galtier F, Gervais P, Hwang SJ, McNeil S, Richardus JH, Trofa A, Oostvogels L; Influence65 study group.

Hum Vaccin Immunother. 2016 Dec;12(12):3043-3055. doi: 10.1080/21645515.2016.1219809.

13.

Epidemiology and clinical characteristics of respiratory syncytial virus infections among children and adults in Mexico.

Gamiño-Arroyo AE, Moreno-Espinosa S, Llamosas-Gallardo B, Ortiz-Hernández AA, Guerrero ML, Galindo-Fraga A, Galán-Herrera JF, Prado-Galbarro FJ, Beigel JH, Ruiz-Palacios GM, Noyola DE; Mexico Emerging Infectious Diseases Clinical Research Network (La Red).

Influenza Other Respir Viruses. 2017 Jan;11(1):48-56. doi: 10.1111/irv.12414. Epub 2016 Aug 18.

14.

Fecal Polyomavirus Excretion in Infancy.

Vanchiere JA, Carillo B, Morrow AL, Jiang X, Ruiz-Palacios GM, Butel JS.

J Pediatric Infect Dis Soc. 2016 Jun;5(2):210-3. doi: 10.1093/jpids/piu101. Epub 2014 Oct 15.

15.

Clinical characteristics of asthmatic patients with influenza-like illness and risk of severe exacerbations in Mexico.

Paulin-Prado P, Nishimura K, Freimanis-Hance L, Hunsberger S, Beigel J, Fraga AG, Ortiz Hernandez AA, Llamosas-Gallardo B, Moreno-Espinosa S, Magaña-Aquino M, Ruiz Palacios GM, Ramirez-Venegas A; Mexico Emerging Infectious Diseases Clinical Research Network.

Ann Allergy Asthma Immunol. 2016 May;116(5):402-7. doi: 10.1016/j.anai.2016.03.007. Epub 2016 Apr 1.

16.

Development of the Flu-PRO: a patient-reported outcome (PRO) instrument to evaluate symptoms of influenza.

Powers JH, Guerrero ML, Leidy NK, Fairchok MP, Rosenberg A, Hernández A, Stringer S, Schofield C, Rodríguez-Zulueta P, Kim K, Danaher PJ, Ortega-Gallegos H, Bacci ED, Stepp N, Galindo-Fraga A, St Clair K, Rajnik M, McDonough EA, Ridoré M, Arnold JC, Millar EV, Ruiz-Palacios GM.

BMC Infect Dis. 2016 Jan 5;16:1. doi: 10.1186/s12879-015-1330-0.

17.

Longitudinal Development of Infant Complementary Diet Diversity in 3 International Cohorts.

Woo JG, Herbers PM, McMahon RJ, Davidson BS, Ruiz-Palacios GM, Peng YM, Morrow AL.

J Pediatr. 2015 Nov;167(5):969-74.e1. doi: 10.1016/j.jpeds.2015.06.063. Epub 2015 Jul 27.

PMID:
26227436
18.

Circulating levels of miR-150 are associated with poorer outcomes of A/H1N1 infection.

Morán J, Ramírez-Martínez G, Jiménez-Alvarez L, Cruz A, Pérez-Patrigeon S, Hidalgo A, Orozco L, Martínez A, Padilla-Noriega L, Avila-Moreno F, Cabello C, Granados J, Ortíz-Quintero B, Ramírez-Venegas A, Ruíz-Palacios GM, Zlotnik A, Merino E, Zúñiga J.

Exp Mol Pathol. 2015 Oct;99(2):253-61. doi: 10.1016/j.yexmp.2015.07.001. Epub 2015 Jul 3.

PMID:
26148929
19.

Sun exposure and vitamin D supplementation in relation to vitamin D status of breastfeeding mothers and infants in the global exploration of human milk study.

Dawodu A, Davidson B, Woo JG, Peng YM, Ruiz-Palacios GM, de Lourdes Guerrero M, Morrow AL.

Nutrients. 2015 Feb 5;7(2):1081-93. doi: 10.3390/nu7021081.

20.

Open-label trial of immunogenicity and safety of a 13-valent pneumococcal conjugate vaccine in adults ≥ 50 years of age in Mexico.

Tinoco JC, Juergens C, Ruiz Palacios GM, Vazquez-Narvaez J, Enkerlin-Pauwells HL, Sundaraiyer V, Pathirana S, Kalinina E, Gruber WC, Scott DA, Schmoele-Thoma B.

Clin Vaccine Immunol. 2015 Feb;22(2):185-92. doi: 10.1128/CVI.00711-14. Epub 2014 Dec 10.

21.

Genetic and antigenic typing of seasonal influenza virus breakthrough cases from a 2008-2009 vaccine efficacy trial.

Durviaux S, Treanor J, Beran J, Duval X, Esen M, Feldman G, Frey SE, Launay O, Leroux-Roels G, McElhaney JE, Nowakowski A, Ruiz-Palacios GM, van Essen GA, Oostvogels L, Devaster JM, Walravens K.

Clin Vaccine Immunol. 2014 Mar;21(3):271-9. doi: 10.1128/CVI.00544-13. Epub 2013 Dec 26.

22.

AS03-adjuvanted versus non-adjuvanted inactivated trivalent influenza vaccine against seasonal influenza in elderly people: a phase 3 randomised trial.

McElhaney JE, Beran J, Devaster JM, Esen M, Launay O, Leroux-Roels G, Ruiz-Palacios GM, van Essen GA, Caplanusi A, Claeys C, Durand C, Duval X, El Idrissi M, Falsey AR, Feldman G, Frey SE, Galtier F, Hwang SJ, Innis BL, Kovac M, Kremsner P, McNeil S, Nowakowski A, Richardus JH, Trofa A, Oostvogels L; Influence65 study group.

Lancet Infect Dis. 2013 Jun;13(6):485-96. doi: 10.1016/S1473-3099(13)70046-X. Epub 2013 Mar 19.

PMID:
23518156
23.

What do we know about Q fever in Mexico?

Araujo-Meléndez J, Sifuentes-Osornio J, Bobadilla-Del-valle JM, Aguilar-Cruz A, Torres-Angeles O, Ramírez-González JL, Ponce-de-León A, Ruiz-Palacios GM, Guerrero-Almeida ML.

Rev Invest Clin. 2012 Nov-Dec;64(6 Pt 1):541-5.

PMID:
23513611
24.

Clinical characteristics and outcomes of influenza and other influenza-like illnesses in Mexico City.

Galindo-Fraga A, Ortiz-Hernández AA, Ramírez-Venegas A, Vázquez RV, Moreno-Espinosa S, Llamosas-Gallardo B, Pérez-Patrigeon S, Salinger M, Freimanis L, Huang CY, Gu W, Guerrero ML, Beigel J, Ruiz-Palacios GM; La Red ILI 002 Study Group.

Int J Infect Dis. 2013 Jul;17(7):e510-7. doi: 10.1016/j.ijid.2013.01.006. Epub 2013 Feb 14.

25.

Prevalence of pneumococcal disease, serotype distribution, and antimicrobial susceptibility in Mexican children younger than 5 years of age.

Bautista-Márquez A, Richardson V, Ortiz-Orozco O, Luna-Cruz ME, Carnalla-Barajas MN, Echaniz-Avilés G, Bobadilla-del Valle M, Martínez-Medina L, Montalvo-Vázquez AM, de la Re-Montaño N, Anchondo-Martínez I, Tinoco-Favila JC, Martínez-Aguilar G, Yberri-Zárate I, Girón-Hernández JA, Sifuentes-Osornio J, Guerrero ML, Ruiz-Palacios GM.

Arch Med Res. 2013 Feb;44(2):142-50. doi: 10.1016/j.arcmed.2012.12.005. Epub 2013 Jan 4.

PMID:
23291380
26.

Specific infant feeding practices do not consistently explain variation in anthropometry at age 1 year in urban United States, Mexico, and China cohorts.

Woo JG, Guerrero ML, Ruiz-Palacios GM, Peng YM, Herbers PM, Yao W, Ortega H, Davidson BS, McMahon RJ, Morrow AL.

J Nutr. 2013 Feb;143(2):166-74. doi: 10.3945/jn.112.163857. Epub 2012 Dec 12.

27.

Immunogenicity and safety of a booster dose of the 10-valent pneumococcal Haemophilus influenzae protein D conjugate vaccine coadministered with the tetravalent meningococcal serogroups A, C, W-135 and Y tetanus toxoid conjugate vaccine in toddlers: a randomized trial.

Ruiz-Palacios GM, Huang LM, Lin TY, Hernandez L, Guerrero ML, Villalobos AL, Van der Wielen M, Moreira M, Fissette L, Borys D, Miller JM.

Pediatr Infect Dis J. 2013 Jan;32(1):62-71. doi: 10.1097/INF.0b013e3182784143.

PMID:
23076383
28.

Dose-range study of MF59-adjuvanted versus nonadjuvanted monovalent A/H1N1 pandemic influenza vaccine in six- to less than thirty-six-month-old children.

Block SL, Ruiz-Palacios GM, Guerrero ML, Beygo J, Sales V, Holmes SJ.

Pediatr Infect Dis J. 2012 Jul;31(7):e92-8. doi: 10.1097/INF.0b013e318257644f.

PMID:
22481427
29.

Human milk adiponectin affects infant weight trajectory during the second year of life.

Woo JG, Guerrero ML, Guo F, Martin LJ, Davidson BS, Ortega H, Ruiz-Palacios GM, Morrow AL.

J Pediatr Gastroenterol Nutr. 2012 Apr;54(4):532-9. doi: 10.1097/MPG.0b013e31823fde04.

30.

Immunogenicity, reactogenicity and safety of the 10-valent pneumococcal nontypeable Haemophilus influenzae protein D conjugate vaccine (PHiD-CV) in Mexican infants.

Ruiz-Palacios GM, Guerrero ML, Hernández-Delgado L, Lavalle-Villalobos A, Casas-Muñoz A, Cervantes-Apolinar Y, Moreira M, Schuerman L.

Hum Vaccin. 2011 Nov;7(11):1137-45. doi: 10.4161/hv.7.11.17984. Epub 2011 Nov 1.

PMID:
22048109
31.

An influenza A/H1N1/2009 hemagglutinin vaccine produced in Escherichia coli.

Aguilar-Yáñez JM, Portillo-Lara R, Mendoza-Ochoa GI, García-Echauri SA, López-Pacheco F, Bulnes-Abundis D, Salgado-Gallegos J, Lara-Mayorga IM, Webb-Vargas Y, León-Angel FO, Rivero-Aranda RE, Oropeza-Almazán Y, Ruiz-Palacios GM, Zertuche-Guerra MI, DuBois RM, White SW, Schultz-Cherry S, Russell CJ, Alvarez MM.

PLoS One. 2010 Jul 22;5(7):e11694. doi: 10.1371/journal.pone.0011694.

32.

Organization of a third-level care hospital in Mexico City during the 2009 influenza epidemic.

Bourlon MT, Macias AE, de la Torre A, Gulias-Herrero A, Leal PE, Domínguez-Cherit G, Huertas M, Ruiz-Palacios GM.

Arch Med Res. 2009 Nov;40(8):681-6. doi: 10.1016/j.arcmed.2009.10.009. Epub 2010 Jan 29. Review.

PMID:
20304257
33.

Rapid detection of ESBL-producing gram-negative bacteria isolated from blood: a reasonable and reliable tool for middle and low resource countries.

Cuellar-Rodríguez JM, Ponce-De-León A, Quiroz-Mejía R, Galindo-Fraga A, Rolón-Montes-de-Oca AL, Hernández-Durán M, Ruiz-Palacios GM, Sifuentes-Osornio J.

Rev Invest Clin. 2009 Jul-Aug;61(4):306-12.

PMID:
19848308
34.

Early loss of measles antibodies after MMR vaccine among HIV-infected adults receiving HAART.

Belaunzarán-Zamudio PF, García-León ML, Wong-Chew RM, Villasís-Keever A, Cuellar-Rodríguez J, Mosqueda-Gómez JL, Muñoz-Trejo T, Escobedo K, Santos JI, Ruiz-Palacios GM, Sierra-Madero JG.

Vaccine. 2009 Nov 23;27(50):7059-64. doi: 10.1016/j.vaccine.2009.09.063. Epub 2009 Sep 30.

PMID:
19799846
35.

Controlling the novel A (H1N1) influenza virus: don't touch your face!

Macias AE, de la Torre A, Moreno-Espinosa S, Leal PE, Bourlon MT, Ruiz-Palacios GM.

J Hosp Infect. 2009 Nov;73(3):280-1. doi: 10.1016/j.jhin.2009.06.017. Epub 2009 Aug 20. No abstract available.

PMID:
19699011
36.

[Epidemic influenza in Mexico: the broken dogma and its lessons].

Macías AE, De la Torre A, Bourlon MT, Leal PE, Moreno-Espinosa S, Huertas M, Domínguez-Cherit G, Galindo-Fraga A, Ruiz-Palacios GM.

Rev Invest Clin. 2009 Mar-Apr;61(2):94-7. Spanish. No abstract available.

PMID:
19637722
37.

Patient-oriented pandemic influenza research.

Tran TH, Ruiz-Palacios GM, Hayden FG, Farrar J.

Lancet. 2009 Jun 20;373(9681):2085-6. doi: 10.1016/S0140-6736(09)61131-4. No abstract available.

PMID:
19541022
38.

Human milk adiponectin is associated with infant growth in two independent cohorts.

Woo JG, Guerrero ML, Altaye M, Ruiz-Palacios GM, Martin LJ, Dubert-Ferrandon A, Newburg DS, Morrow AL.

Breastfeed Med. 2009 Jun;4(2):101-9. doi: 10.1089/bfm.2008.0137.

39.

Efficacy and safety of an oral live attenuated human rotavirus vaccine against rotavirus gastroenteritis during the first 2 years of life in Latin American infants: a randomised, double-blind, placebo-controlled phase III study.

Linhares AC, Velázquez FR, Pérez-Schael I, Sáez-Llorens X, Abate H, Espinoza F, López P, Macías-Parra M, Ortega-Barría E, Rivera-Medina DM, Rivera L, Pavía-Ruz N, Nuñez E, Damaso S, Ruiz-Palacios GM, De Vos B, O'Ryan M, Gillard P, Bouckenooghe A; Human Rotavirus Vaccine Study Group.

Lancet. 2008 Apr 5;371(9619):1181-9. doi: 10.1016/S0140-6736(08)60524-3.

PMID:
18395579
40.

Improving outcome of human immunodeficiency virus-infected patients in a Mexican intensive care unit.

Vargas-Infante YA, Guerrero ML, Ruiz-Palacios GM, Soto-Ramírez LE, Del Río C, Carranza J, Domínguez-Cherit G, Sierra-Madero JG.

Arch Med Res. 2007 Nov;38(8):827-33. Epub 2007 Aug 20.

PMID:
17923262
41.

Efficacy of the human rotavirus vaccine RIX4414 in malnourished children.

Perez-Schael I, Salinas B, Tomat M, Linhares AC, Guerrero ML, Ruiz-Palacios GM, Bouckenooghe A, Yarzabal JP.

J Infect Dis. 2007 Aug 15;196(4):537-40. Epub 2007 Jun 29.

PMID:
17624838
42.

Dose response and efficacy of a live, attenuated human rotavirus vaccine in Mexican infants.

Ruiz-Palacios GM, Guerrero ML, Bautista-Márquez A, Ortega-Gallegos H, Tuz-Dzib F, Reyes-González L, Rosales-Pedraza G, Martínez-López J, Castañón-Acosta E, Cervantes Y, Costa-Clemens S, DeVos B.

Pediatrics. 2007 Aug;120(2):e253-61. Epub 2007 Jul 2.

PMID:
17606534
43.

[Fluoroquinolone prophylaxis utility during chemotherapy-induced severe neutropenia in patients with acute leukemia, with fluoroquinolone resistance high prevalence, in a reference hospital in Mexico City].

Ugarte-Torres A, Villasis-Keever A, Hernández-Bribiesca ME, Crespo-Solis E, Ruiz-Palacios GM, Sifuentes-Osornio J, Ponce-De-León-Garduño A.

Rev Invest Clin. 2006 Nov-Dec;58(6):547-54. Spanish.

PMID:
17432285
44.

Salt and stress synergize H. pylori-induced gastric lesions, cell proliferation, and p21 expression in Mongolian gerbils.

Gamboa-Dominguez A, Ubbelohde T, Saqui-Salces M, Romano-Mazzoti L, Cervantes M, Domínguez-Fonseca C, de la Luz Estreber M, Ruíz-Palacios GM.

Dig Dis Sci. 2007 Jun;52(6):1517-26. Epub 2007 Apr 3.

PMID:
17404882
45.

The health burden of Campylobacter infection and the impact of antimicrobial resistance: playing chicken.

Ruiz-Palacios GM.

Clin Infect Dis. 2007 Mar 1;44(5):701-3. Epub 2007 Jan 25. No abstract available.

PMID:
17278063
46.

Adiponectin is present in human milk and is associated with maternal factors.

Martin LJ, Woo JG, Geraghty SR, Altaye M, Davidson BS, Banach W, Dolan LM, Ruiz-Palacios GM, Morrow AL.

Am J Clin Nutr. 2006 May;83(5):1106-11.

PMID:
16685053
47.

Risk of infant anemia is associated with exclusive breast-feeding and maternal anemia in a Mexican cohort.

Meinzen-Derr JK, Guerrero ML, Altaye M, Ortega-Gallegos H, Ruiz-Palacios GM, Morrow AL.

J Nutr. 2006 Feb;136(2):452-8.

PMID:
16424127
48.

Safety and efficacy of an attenuated vaccine against severe rotavirus gastroenteritis.

Ruiz-Palacios GM, Pérez-Schael I, Velázquez FR, Abate H, Breuer T, Clemens SC, Cheuvart B, Espinoza F, Gillard P, Innis BL, Cervantes Y, Linhares AC, López P, Macías-Parra M, Ortega-Barría E, Richardson V, Rivera-Medina DM, Rivera L, Salinas B, Pavía-Ruz N, Salmerón J, Rüttimann R, Tinoco JC, Rubio P, Nuñez E, Guerrero ML, Yarzábal JP, Damaso S, Tornieporth N, Sáez-Llorens X, Vergara RF, Vesikari T, Bouckenooghe A, Clemens R, De Vos B, O'Ryan M; Human Rotavirus Vaccine Study Group.

N Engl J Med. 2006 Jan 5;354(1):11-22.

49.

Evaluation of safety, immunogenicity and efficacy of an attenuated rotavirus vaccine, RIX4414: A randomized, placebo-controlled trial in Latin American infants.

Salinas B, Pérez Schael I, Linhares AC, Ruiz Palacios GM, Guerrero ML, Yarzábal JP, Cervantes Y, Costa Clemens S, Damaso S, Hardt K, De Vos B.

Pediatr Infect Dis J. 2005 Sep;24(9):807-16.

PMID:
16148848
50.

A short report on highlights of world-wide development of RIX4414: a Latin American experience.

Linhares AC, Ruiz-Palacios GM, Guerrero ML, Salinas B, Perez-Schael I, Clemens SA, Innis B, Yarzabal JP, Vespa G, Cervantes Y, Hardt K, De Vos B.

Vaccine. 2006 May 1;24(18):3784-5. Epub 2005 Jul 26.

PMID:
16098636

Supplemental Content

Loading ...
Support Center